Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
23.28 USD | -0.36% | -5.45% | -17.05% |
04-26 | North American Morning Briefing : Tech Still in -2- | DJ |
04-25 | JPMorgan Upgrades Doximity to Neutral Rating From Underweight, Price Target is $25 | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-17.05% | 4.36B | |
+28.81% | 441B | |
+25.93% | 263B | |
+7.02% | 140B | |
+8.01% | 92.89B | |
+28.40% | 90.53B | |
+54.37% | 58.64B | |
+16.97% | 46.96B | |
+2.27% | 36.7B | |
+20.56% | 36.11B |
- Stock Market
- Equities
- DOCS Stock
- News Doximity, Inc.
- Doximity Guides For Q3 Revenue of $127-$128 Million, vs CIQ Analyst Consensus of $123 Million; FY 2024 Revenue Seen at $460-$472 Million, vs Consensus of $461 Million